| pubmed-article:16857790 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C1551338 | lld:lifeskim |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C0205112 | lld:lifeskim |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:16857790 | lifeskim:mentions | umls-concept:C0699493 | lld:lifeskim |
| pubmed-article:16857790 | pubmed:issue | 14 Pt 1 | lld:pubmed |
| pubmed-article:16857790 | pubmed:dateCreated | 2006-7-21 | lld:pubmed |
| pubmed-article:16857790 | pubmed:abstractText | Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that is typically hormone receptor negative and shows a distinct gene expression profile. Based on variable basal cytokeratin immunostaining patterns, we hypothesized that the "basal phenotype" tumor group may comprise more than one biological entity. | lld:pubmed |
| pubmed-article:16857790 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16857790 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16857790 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16857790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16857790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16857790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16857790 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16857790 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16857790 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:TannerMinnaM | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:IsolaJormaJ | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:BerghJonasJ | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:WiklundTomT | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:MalmströmPerP | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:Kellokumpu-Le... | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:NilssonJonasJ | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:WilkingNilsN | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:LaaksoMerviM | lld:pubmed |
| pubmed-article:16857790 | pubmed:author | pubmed-author:EriksteinBjör... | lld:pubmed |
| pubmed-article:16857790 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16857790 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:16857790 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:16857790 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16857790 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16857790 | pubmed:pagination | 4185-91 | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:meshHeading | pubmed-meshheading:16857790... | lld:pubmed |
| pubmed-article:16857790 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16857790 | pubmed:articleTitle | Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. | lld:pubmed |
| pubmed-article:16857790 | pubmed:affiliation | Department of Pathology, Seinäjoki Central Hospital, Seinäjoki, Finland. mervi.laakso@epshp.fi | lld:pubmed |
| pubmed-article:16857790 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16857790 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16857790 | lld:pubmed |
